News & Events about Acumen Pharmaceuticals Inc.
CHARLOTTESVILLE, Va. and CARMEL, Ind., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (Acumen or the Company), a clinical-stage biopharmaceutical company focused on the development of novel targeted therapeutics for Alzheimers disease (AD), today announced Derrell ...
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS Get Rating) saw a significant increase in short interest in the month of December. As of December 15th, there was short interest totalling 875,700 shares, an increase of 24.3% from the November 30th total of 704,700 shares. Currently, 3.5% of the ...
Market News Video
1month ago
In trading on Tuesday, shares of Acumen Pharmaceuticals Inc (ABOS) crossed below their 200 day moving average of 5.42, changing hands as low as 5.30 per share. Acumen Pharmaceuticals Inc shares are currently trading down about 5% on the day...
Thinking about buying stock in Acumen Pharmaceuticals, Delta Air Lines, Blue Apron, United Airlines, or SeaSpine Holdings? Thinking about buying stock in Acumen Pharmaceuticals, Delta Air Lines, Blue Apron, United Airlines, or SeaSpine Holdings? PR Newswire NEW YORK, Oct. 11, 2022 NEW YORK, Oct...